David Packham

5.5k total citations · 1 hit paper
70 papers, 2.6k citations indexed

About

David Packham is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, David Packham has authored 70 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Nephrology, 18 papers in Pulmonary and Respiratory Medicine and 14 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in David Packham's work include Renal Diseases and Glomerulopathies (21 papers), Chronic Kidney Disease and Diabetes (18 papers) and Potassium and Related Disorders (14 papers). David Packham is often cited by papers focused on Renal Diseases and Glomerulopathies (21 papers), Chronic Kidney Disease and Diabetes (18 papers) and Potassium and Related Disorders (14 papers). David Packham collaborates with scholars based in Australia, United States and Netherlands. David Packham's co-authors include Simon D. Roger, K. F. Fairley, Philip T. Lavin, Bhupinder Singh, Henrik Rasmussen, Wajeh Y. Qunibi, Mikhail Kosiborod, Bruce Spinowitz, Edgar V. Lerma and Hiddo J.L. Heerspink and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

David Packham

68 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sodium Zirconium Cyclosilicate in Hyperkalemia

2014 352 citations David Packham, Philip T. Lavin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Packham Australia	24	963	821	614	462	414	70	2.6k
Bruce Spinowitz United States	24	983 1.0×	897 1.1×	411 0.7×	446 1.0×	304 0.7×	84	2.8k
Anjay Rastogi United States	27	557 0.6×	1.0k 1.2×	387 0.6×	139 0.3×	175 0.4×	114	2.4k
James D. Krier United States	30	1.2k 1.3×	450 0.5×	476 0.8×	165 0.4×	150 0.4×	60	2.7k
Georg Schlieper Germany	30	622 0.6×	1.4k 1.8×	645 1.1×	84 0.2×	257 0.6×	83	3.1k
Radovan Hojs Slovenia	24	374 0.4×	1.1k 1.4×	546 0.9×	88 0.2×	429 1.0×	136	2.6k
Mohsen Agharazii Canada	30	535 0.6×	797 1.0×	952 1.6×	66 0.1×	259 0.6×	114	2.5k
Michael Hennig Germany	31	695 0.7×	331 0.4×	1.2k 2.0×	122 0.3×	243 0.6×	70	3.1k
Shuzo Kobayashi Japan	30	719 0.7×	1.3k 1.6×	712 1.2×	62 0.1×	518 1.3×	185	3.3k
Yadon Arad United States	20	582 0.6×	260 0.3×	1.9k 3.1×	569 1.2×	797 1.9×	34	4.4k
Robert Ekart Slovenia	24	324 0.3×	925 1.1×	489 0.8×	96 0.2×	366 0.9×	121	2.1k

Countries citing papers authored by David Packham

Since Specialization

Citations

This map shows the geographic impact of David Packham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Packham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Packham more than expected).

Fields of papers citing papers by David Packham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Packham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Packham. The network helps show where David Packham may publish in the future.

Co-authorship network of co-authors of David Packham

This figure shows the co-authorship network connecting the top 25 collaborators of David Packham. A scholar is included among the top collaborators of David Packham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Packham. David Packham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barratt, Jonathan, Sung Gyun Kim, Lesley A. Inker, et al.. (2025). WCN25-778 AFFINITY study: 1-year results of atrasentan in IgA nephropathy (IgAN). Kidney International Reports. 10(2). S183–S183. 1 indexed citations

Packham, David, Anjay Rastogi, Michelle N. Rheault, et al.. (2023). WCN23-1126 ATRASENTAN FOR THE TREATMENT OF IGA NEPHROPATHY: INTERIM RESULTS OF THE AFFINITY STUDY. Kidney International Reports. 8(9). 1902–1902. 9 indexed citations

Roger, Simon D., David W. Mudge, Craig Nelson, et al.. (2022). The ACTION (AT1R and CCR2 Targets for Inflammatory Nephrosis) Program in Focal Segmental Glomerulosclerosis. Journal of the American Society of Nephrology. 33(11S). 798–798.

Roger, Simon D., Bruce Spinowitz, Edgar V. Lerma, et al.. (2019). Efficacy and Safety of Sodium Zirconium Cyclosilicate for Treatment of Hyperkalemia: An 11-Month Open-Label Extension of HARMONIZE. American Journal of Nephrology. 50(6). 473–480. 54 indexed citations

Rossing, Peter, Geoffrey A. Block, Melanie Chin, et al.. (2019). Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease. Kidney International. 96(4). 1030–1036. 30 indexed citations

McCullough, P. R., Pablo E. Pérgola, Steven Fishbane, et al.. (2017). Abstract 16610: Efficacy and Safety of Sodium Zirconium Cyclosilicate to Treat Hyperkalemia Among Patients Taking Renin-Angiotensin-Aldosterone System Inhibitors in a 12-Month, Open-Label, Phase 3 Study: A Post Hoc Subgroup Analysis. Circulation. 2 indexed citations

Packham, David, et al.. (2016). Allogeneic Mesenchymal Precursor Cells (MPC) in Diabetic Nephropathy: A Randomized, Placebo-controlled, Dose Escalation Study. EBioMedicine. 12. 263–269. 119 indexed citations

Chin, Melanie, Scott A. Reisman, George L. Bakris, et al.. (2014). Mechanisms Contributing to Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated with Bardoxolone Methyl. American Journal of Nephrology. 39(6). 499–508. 125 indexed citations

Dwyer, Jamie P., Barbara Greco, Kausik Umanath, et al.. (2014). Pyridoxamine Dihydrochloride in Diabetic Nephropathy (PIONEER-CSG-17): Lessons Learned from a Pilot Study. The Nephron journals/Nephron journals. 129(1). 22–28. 29 indexed citations

10.

Packham, David, Jamie P. Dwyer, Robert C. Atkins, et al.. (2011). Relative Incidence of ESRD Versus Cardiovascular Mortality in Proteinuric Type 2 Diabetes and Nephropathy: Results From the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) Database. American Journal of Kidney Diseases. 59(1). 75–83. 162 indexed citations

11.

Lewis, Edmund J., Julia B. Lewis, Tom Greene, et al.. (2011). Sulodexide for Kidney Protection in Type 2 Diabetes Patients With Microalbuminuria: A Randomized Controlled Trial. American Journal of Kidney Diseases. 58(5). 729–736. 86 indexed citations

12.

Packham, David, Anne T. Reutens, Rory Wolfe, et al.. (2011). Proteinuria in Type 2 Diabetic Patients with Renal Impairment: The Changing Face of Diabetic Nephropathy. Nephron Clinical Practice. 118(4). c331–c338. 9 indexed citations

13.

Packham, David. (2005). Hematuria in Thin Basement Membrane Nephropathy. Seminars in Nephrology. 25(3). 146–148. 7 indexed citations

14.

Nelson, Craig, Connie Karschimkus, George Dragicevic, et al.. (2005). Systemic and vascular inflammation is elevated in early IgA and type 1 diabetic nephropathies and relates to vascular disease risk factors and renal function. Nephrology Dialysis Transplantation. 20(11). 2420–2426. 49 indexed citations

15.

Kincaid‐Smith, Priscilla, K. F. Fairley, & David Packham. (2004). Dual blockade of the renin-angiotensin system compared with a 50% increase in the dose of angiotensin-converting enzyme inhibitor: effects on proteinuria and blood pressure. Nephrology Dialysis Transplantation. 19(9). 2272–2274. 15 indexed citations

16.

Kincaid‐Smith, Priscilla, K. F. Fairley, & David Packham. (2002). Randomized controlled crossover study of the effect on proteinuria and blood pressure of adding an angiotensin II receptor antagonist to an angiotensin converting enzyme inhibitor in normotensive patients with chronic renal disease and proteinuria. Nephrology Dialysis Transplantation. 17(4). 597–601. 71 indexed citations

17.

Stein, Mark S., David Packham, Peter R. Ebeling, John D. Wark, & Gavin J. Becker. (1996). Prevalence and risk factors for osteopenia in dialysis patients. American Journal of Kidney Diseases. 28(4). 515–522. 114 indexed citations

18.

Packham, David, et al.. (1994). Pregnancy-Related Complications in Women With Reflux Nephropathy. Obstetrical & Gynecological Survey. 49(10). 665–666. 33 indexed citations

19.

Fairley, Christopher K. & David Packham. (1989). Glomerular Crescents and Pregnancy. American Journal of Kidney Diseases. 13(3). 250–252. 2 indexed citations

20.

Packham, David & K. F. Fairley. (1987). Renal biopsy: indications and complications in pregnancy. BJOG An International Journal of Obstetrics & Gynaecology. 94(10). 935–939. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact